Responses
Regular and young investigator award abstracts
Novel single-agent immunotherapies
689 ATRC-101 Drives Potent Single-Agent Activity in Mouse Syngeneic Tumor Models via a Novel Cellular Mechanism of Action
Compose a Response to This Article
Other responses
No responses have been published for this article.
